publication date: Mar. 18, 2016

Yanai to Lead New Institute for Computational Medicine at NYU Langone Medical Center 


ITAI YANAI was named the inaugural director of the Institute for Computational Medicine at NYU Langone Medical Center, effective May 1.

The Institute for Computational Medicine will act as the hub for multidisciplinary efforts to reveal patterns in medical data to aid in diagnoses and the design of new treatments.

Yanai will also hold the academic title of professor in the Department of Biochemistry and Molecular Pharmacology at NYU School of Medicine. He comes to NYU Langone from the Technion-Israel Institute of Technology, where, since 2008, he served as a research leader in the study of gene regulation. Using experimental approaches in embryology, molecular biology, and computational biology, he has explored the principles by which developmental pathways evolve.


DEBRA PATT was named editor-in-chief of JCO Clinical Cancer Informatics, a new publication of the American Society of Clinical Oncology.

Patt, who specializes in medical oncology and hematology, is a vice president of Texas Oncology, and medical director of outcomes research and the pathways task force for The US Oncology Network. She was formerly medical director of healthcare informatics for McKesson Specialty Health. Her primary research interests are in health services research, health economics outcomes research, and health policy.

JCO CCI will be a peer-reviewed, interdisciplinary journal publishing clinically relevant research covering policy, healthcare services delivery, and clinical insights based on biomedical informatics methods and processes applied to cancer-related data. The first issue of … Continue reading 42-11 Yanai to Lead New Institute For Computational Medicine At NYU Langone Medical Center

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.